Publications

Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

Download PDF
Resource: Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma

.

Related Articles

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer

Link
B cell-based therapy produces antibodies that inhibit glioblastoma growth

Link